The Spanish pharma company Accure Therapeutics has announced the appointment of Rossella Medori as its chief medical officer. Dr Medori has over thirty years of experience in pharma and biotech, and has held leadership roles at Biogen Inc, Janssen, Eli Lilly and Co and others. At Accure, she will focus first on the completion of a Phase 2 programme of Accure’s asset in multiple sclerosis and acute optic neuritis. Dr Medori is a member of the American Academy of Neurology and the author of numerous publications on multiple sclerosis, Parkinson’s disease, prion diseases and schizophrenia.
Accure Therapeutics announced the appointment on 26 January 2021.
Copyright 2021 Evernow Publishing Ltd